HomeC68 โข FRA
add
Crescent Biopharma Inc
Previous close
โฌ9.50
Year range
โฌ7.85 - โฌ12.40
Market cap
164.77M USD
Avg Volume
16.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | โ | โ |
Operating expense | 25.88M | โ |
Net income | -24.61M | โ |
Net profit margin | โ | โ |
Earnings per share | -1.37 | โ |
EBITDA | -25.86M | โ |
Effective tax rate | โ | โ |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 133.26M | โ |
Total assets | 138.27M | โ |
Total liabilities | 21.63M | โ |
Total equity | 116.64M | โ |
Shares outstanding | 19.55M | โ |
Price to book | 1.65 | โ |
Return on assets | -43.77% | โ |
Return on capital | -49.92% | โ |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -24.61M | โ |
Cash from operations | -17.54M | โ |
Cash from investing | -586.00K | โ |
Cash from financing | -1.25M | โ |
Net change in cash | -19.38M | โ |
Free cash flow | -11.12M | โ |
About
Founded
2024
Headquarters
Website
Employees
41
